<!doctype html>
<html>
<head>
<meta charset="UTF-8">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="viewport" content="width=device-width initial-scale=1, user-scalable=no">
<meta name="apple-mobile-web-app-title" content="AstraZeneca | LYNPARZA">
<title>AstraZeneca | LYNPARZA</title>
<link rel="stylesheet" type="text/css" href="css/animate.min.css" />
<link rel="stylesheet" type="text/css" href="css/swiper.min.css" />
<link rel="stylesheet" type="text/css" href="css/style.css" />
<style type="text/css">
	.content > h2 { margin-bottom:70px; }
	.swiper-container.swiper-scroll { width:944px; height:400px; }
	ol > li { margin-bottom:10px; font-size:16px; line-height:22px; }
	
</style> 
</head>
<body>
	<section id="container">
    	<nav class="nav-top icon">
            <ul>
                <li data-href="home"></li>
                <li data-href="warning">Contraindications<br />and Warnings</li>
                <li data-href="pi">PI</li>
                <li data-href="bibliography"></li>
                <li data-href="resource"></li>
                <li data-href="menu"></li>
            </ul>
        </nav>
    	<article class="content">
        	<!--subslides-->
            <h2>REFERENCES</h2>
            <div class="swiper-container swiper-scroll">
                <ul class="swiper-wrapper">
                	<!-- slide 23-->
                    <li class="swiper-slide" data-slide="23">
                 		 <ol>
                         	<li> Weil, MK. and Chen, M.D. 2011. PARP inhibitor treatment in ovarian and breast cancer. Curr Prob Cancer. 35(1), pp.7–50.</li>
                         	<li>Ledermann, J. et al. 2012. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N Engl J Med. 366
(15), pp.1382-1392.</li>
                         	<li>Ledermann, J. et al. 2014. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian
cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomized phase 2 trial. Lancet Oncol. 15(8),
pp.852-856.</li>
                         	<li>Lynparza (olaparib) Approved Product Information. 7 January 2016</li>
                         	<li>Goff, B.A. et al. 2000. Ovarian carcinoma diagnosis. Cancer. 89(10), pp.2068-75.</li>
                         	<li>Ledermann, J. and Raja, F.A. et al. 2013. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24(6), pp.24-32.</li>
                         	<li>Caldecott, K.W. 2003. Protein–proteins interactions during mammalian DNA singlestrand break repair. Biochem Soc Trans. 31 (Pt 1), pp.247-251.</li>
                         	<li>Langelier, M.F. et al. 2014. PARP-2 and PARP-3 are selectively activated by 5 phosphorylated DNA breaks through an
allosteric regulatory mechanism shared with PARP-1. Nucleic Acids Res. 42(12), pp.7762-7775.</li>
                         	<li>Hegde, M.L. et al. 2008. Early Steps in the DNA Base Excision/Single-Strand Interruption Repair Pathway in Mammalian
Cells. Cell Res. 18(1), pp.27–47.</li>
                         	<li>Amal, A. and Ganesan. S. 2011. BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. Journal of
Molecular Cell Biology. 3, pp. 66-74.</li>
                         </ol>
         
            		</li>
                    
            	</ul><!-- end swiper-wrapper -->
                <!-- Scroll Bar -->
                <div class="swiper-scrollbar"></div>
        	</div>
        	<span class="logo lynp"></span>
            <span class="btn icon btn-arrow brcam hide"><i>BRCAm</i></span>
            <span class="btn btn-info ">i</span>
        </article>
    
    <!-- popup -->
    <div class="overlay shade ">
    	<!-- reference -->
    	<div class="ref hide">
            <div class="item"> <span class="close icon"></span>
                <h1>References</h1>
                <ol></ol>
            </div>
        </div><!-- end ref -->
         <!-- info -->
        <div class="item info " data-info="18"><span class="arrow icon"></span>
        <ul class="list">
        	<li>The recommended dose of Lynparza is 400mg (eight 50mg capsules) taken twice daily, equivalent to a total<br />daily dose of 800 mg<sup data-ref="4">4</sup></li>
<li>Patients should start treatment with Lynparza no later than 8 weeks after completion of their final dose<br />
of the platinum-containing regimen<sup data-ref="4">4</sup></li>
<li>Due to the effect of food on Lynparza absorption, patients should take Lynparza should be take<br />
at the same time relative to time of eating, and preferably after food intake<sup data-ref="4">4</sup></li>
<li>It is recommended that treatment be continued until disease progression of the underlying disease<sup data-ref="4">4</sup></li>
<li>Baseline testing, followed by monthly monitoring, of complete blood counts is recommended for the first<br />
12 months of treatment and periodically after this time to monitor for clinically significant changes in any<br />
parameter during treatment<sup data-ref="4">4</sup></li>
        </ul>
           
        </div><!-- end info -->
       <!-- navigation -->
        <div class="item nav hide"><span class="close icon"></span>
        	<ul class="section">
        		<li data-href="1"><span>Unmet need</span></li>
        		<li data-href="2"><span>Mechanism<br />of action</span>
                	<ul>
                		<li data-href="2"><span>PARPi</span></li>
                		<li data-href="3"><span>DNA repair</span></li>
                	</ul>
                </li>
        		<li data-href="4"><span>Clinical Data</span>
                	<ul>
                		<li data-href="4"><span>Extended PFS</span></li>
                		<li data-href="5"><span>Study overview</span></li>
                		<li data-href="6"><span>BRCAm<br />sub-analysis</span></li>
                		<li data-href="7"><span>TFST<br />Exploratory Analysis</span></li>
                		<li data-href="8"><span>TSST<br />Exploratory Analysis</span></li>
                		<li data-href="9"><span>Overall Survival</span></li>
                		<li data-href="10"><span><em>Post-Hoc</em> interim exploratory analysis of os</span></li>
                		<li data-href="11"><span>Patient Characteristics</span></li>
                	</ul>
                </li>
        		<li data-href="12"><span>BRCAm+</span>
                	<ul>
                		<li data-href="12"><span>BRCAm testing</span></li>
                		<li data-href="13"><span>About BRCAm</span></li>
                		<li data-href="14"><span>Testing<br />guidelines</span></li>
                		<li data-href="15"><span>BRCAm status</span></li>
                	</ul>
                </li>
        		<li data-href="16"><span>Patient<br />Support</span>
                	<ul>
                		<li data-href="16"><span>LYNPARZA Patient&nbsp;Access Programme</span></li>
                		<li data-href="17"><span>Patient&nbsp;Support Programme</span></li>
                		<li data-href="18"><span>Patient<br />Support Kit</span></li>
                		<li data-href="19"><span>Capsule<br />companion</span></li>
                	</ul>
                </li>
        		<li data-href="20"><span>Dosing &amp;<br />administration</span>
                	<ul>
                		<li data-href="20"><span>Safety and<br />tolerability</span></li>
                		<li data-href="21"><span>Dosing</span></li>
                	</ul>
                </li>
        		<li data-href="22"><span>Summary</span></li>
        	</ul>
            
        </div><!-- end nav -->
    </div>

    </section>
<script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="js/TweenMax.min.js"></script>
<script type="text/javascript" src="js/TimelineLite.min.js"></script>
<script type="text/javascript" src="js/swiper.min.js"></script>
<script type="text/javascript" src="js/touchy.js"></script>
<script type="text/javascript" src="js/script.js"></script>
<script type="text/javascript">
	$( function(){
		var swiperScroll = new Swiper('.swiper-scroll', {
			scrollbar: '.swiper-scrollbar',
			direction: 'vertical',
			slidesPerView: 'auto',
			mousewheelControl: true,
			freeMode: true,
			scrollbarDraggable: true,
			scrollbarHide: false
		});
		
	
		/* $('.indicator .arrow').on('tap', function(){ 
				$(this).toggleClass('less').prev('p').slideToggle();
		 })*/
		
	})
</script>
</body>
</html>
